nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—ABCB1—Mitomycin—urinary bladder cancer	0.146	0.247	CbGbCtD
Ranitidine—CYP3A4—Thiotepa—urinary bladder cancer	0.0664	0.112	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—urinary bladder cancer	0.064	0.108	CbGbCtD
Ranitidine—CYP3A5—Etoposide—urinary bladder cancer	0.0462	0.0781	CbGbCtD
Ranitidine—ABCB1—Gemcitabine—urinary bladder cancer	0.0421	0.0712	CbGbCtD
Ranitidine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0412	0.0697	CbGbCtD
Ranitidine—CYP1A2—Etoposide—urinary bladder cancer	0.0344	0.0581	CbGbCtD
Ranitidine—ABCB1—Cisplatin—urinary bladder cancer	0.0306	0.0517	CbGbCtD
Ranitidine—ABCB1—Etoposide—urinary bladder cancer	0.0301	0.0508	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—urinary bladder cancer	0.0205	0.0347	CbGbCtD
Ranitidine—ABCB1—Methotrexate—urinary bladder cancer	0.0199	0.0336	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0193	0.0327	CbGbCtD
Ranitidine—CYP3A4—Etoposide—urinary bladder cancer	0.018	0.0305	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0123	0.0208	CbGbCtD
Ranitidine—SLC22A8—urine—urinary bladder cancer	0.00708	0.149	CbGeAlD
Ranitidine—CYP2C19—urine—urinary bladder cancer	0.00593	0.125	CbGeAlD
Ranitidine—CYP1A2—urine—urinary bladder cancer	0.00485	0.102	CbGeAlD
Ranitidine—CYP3A4—urine—urinary bladder cancer	0.00351	0.074	CbGeAlD
Ranitidine—CYP2D6—urine—urinary bladder cancer	0.00345	0.0729	CbGeAlD
Ranitidine—SLC22A8—prostate gland—urinary bladder cancer	0.00254	0.0536	CbGeAlD
Ranitidine—SLC22A1—renal system—urinary bladder cancer	0.00188	0.0398	CbGeAlD
Ranitidine—SLC22A8—renal system—urinary bladder cancer	0.00173	0.0365	CbGeAlD
Ranitidine—CYP3A5—prostate gland—urinary bladder cancer	0.00168	0.0354	CbGeAlD
Ranitidine—HRH2—lymph node—urinary bladder cancer	0.00137	0.0289	CbGeAlD
Ranitidine—SLC22A1—vagina—urinary bladder cancer	0.00136	0.0288	CbGeAlD
Ranitidine—CYP1A2—renal system—urinary bladder cancer	0.00119	0.025	CbGeAlD
Ranitidine—CYP3A5—renal system—urinary bladder cancer	0.00114	0.0241	CbGeAlD
Ranitidine—CYP2C19—vagina—urinary bladder cancer	0.00105	0.0222	CbGeAlD
Ranitidine—ABCB1—prostate gland—urinary bladder cancer	0.000891	0.0188	CbGeAlD
Ranitidine—CYP3A4—renal system—urinary bladder cancer	0.000858	0.0181	CbGeAlD
Ranitidine—CYP2D6—renal system—urinary bladder cancer	0.000845	0.0178	CbGeAlD
Ranitidine—CYP3A5—vagina—urinary bladder cancer	0.000828	0.0175	CbGeAlD
Ranitidine—ABCB1—seminal vesicle—urinary bladder cancer	0.000754	0.0159	CbGeAlD
Ranitidine—CYP3A4—female reproductive system—urinary bladder cancer	0.000687	0.0145	CbGeAlD
Ranitidine—CYP2D6—female reproductive system—urinary bladder cancer	0.000676	0.0143	CbGeAlD
Ranitidine—ABCB1—epithelium—urinary bladder cancer	0.000655	0.0138	CbGeAlD
Ranitidine—ABCB1—renal system—urinary bladder cancer	0.000608	0.0128	CbGeAlD
Ranitidine—ABCB1—urethra—urinary bladder cancer	0.000597	0.0126	CbGeAlD
Ranitidine—ABCB1—female reproductive system—urinary bladder cancer	0.000487	0.0103	CbGeAlD
Ranitidine—Leukopenia—Etoposide—urinary bladder cancer	0.000455	0.00171	CcSEcCtD
Ranitidine—Hypotension—Gemcitabine—urinary bladder cancer	0.000454	0.0017	CcSEcCtD
Ranitidine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000453	0.0017	CcSEcCtD
Ranitidine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00045	0.00169	CcSEcCtD
Ranitidine—Hypotension—Fluorouracil—urinary bladder cancer	0.000447	0.00167	CcSEcCtD
Ranitidine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000444	0.00166	CcSEcCtD
Ranitidine—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000444	0.00166	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000443	0.00166	CcSEcCtD
Ranitidine—Tachycardia—Cisplatin—urinary bladder cancer	0.000442	0.00166	CcSEcCtD
Ranitidine—ABCB1—vagina—urinary bladder cancer	0.00044	0.00929	CbGeAlD
Ranitidine—Insomnia—Gemcitabine—urinary bladder cancer	0.00044	0.00165	CcSEcCtD
Ranitidine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000438	0.00164	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000435	0.00163	CcSEcCtD
Ranitidine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000433	0.00163	CcSEcCtD
Ranitidine—Chest pain—Etoposide—urinary bladder cancer	0.000433	0.00162	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—urinary bladder cancer	0.000433	0.00162	CcSEcCtD
Ranitidine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000432	0.00162	CcSEcCtD
Ranitidine—Insomnia—Fluorouracil—urinary bladder cancer	0.000432	0.00162	CcSEcCtD
Ranitidine—Somnolence—Gemcitabine—urinary bladder cancer	0.000432	0.00162	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—urinary bladder cancer	0.000429	0.00161	CcSEcCtD
Ranitidine—Discomfort—Etoposide—urinary bladder cancer	0.000428	0.0016	CcSEcCtD
Ranitidine—Breast disorder—Epirubicin—urinary bladder cancer	0.000428	0.0016	CcSEcCtD
Ranitidine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000426	0.0016	CcSEcCtD
Ranitidine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000426	0.0016	CcSEcCtD
Ranitidine—Somnolence—Fluorouracil—urinary bladder cancer	0.000425	0.00159	CcSEcCtD
Ranitidine—Hypotension—Cisplatin—urinary bladder cancer	0.000423	0.00159	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000419	0.00157	CcSEcCtD
Ranitidine—Confusional state—Etoposide—urinary bladder cancer	0.000419	0.00157	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000418	0.00157	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000417	0.00156	CcSEcCtD
Ranitidine—Pain—Gemcitabine—urinary bladder cancer	0.000416	0.00156	CcSEcCtD
Ranitidine—Constipation—Gemcitabine—urinary bladder cancer	0.000416	0.00156	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000415	0.00156	CcSEcCtD
Ranitidine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000415	0.00156	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000413	0.00155	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00041	0.00154	CcSEcCtD
Ranitidine—Dysphagia—Epirubicin—urinary bladder cancer	0.000409	0.00153	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—urinary bladder cancer	0.000409	0.00153	CcSEcCtD
Ranitidine—Pruritus—Thiotepa—urinary bladder cancer	0.000409	0.00153	CcSEcCtD
Ranitidine—Pain—Fluorouracil—urinary bladder cancer	0.000409	0.00153	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000406	0.00152	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—urinary bladder cancer	0.000405	0.00152	CcSEcCtD
Ranitidine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000405	0.00152	CcSEcCtD
Ranitidine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000404	0.00151	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000403	0.00151	CcSEcCtD
Ranitidine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000401	0.0015	CcSEcCtD
Ranitidine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000401	0.0015	CcSEcCtD
Ranitidine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000401	0.0015	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.0004	0.0015	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000399	0.0015	CcSEcCtD
Ranitidine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000399	0.00149	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000396	0.00148	CcSEcCtD
Ranitidine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000395	0.00148	CcSEcCtD
Ranitidine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000394	0.00148	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—urinary bladder cancer	0.000392	0.00147	CcSEcCtD
Ranitidine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000389	0.00146	CcSEcCtD
Ranitidine—Hypotension—Etoposide—urinary bladder cancer	0.000388	0.00145	CcSEcCtD
Ranitidine—Pain—Cisplatin—urinary bladder cancer	0.000387	0.00145	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000386	0.00145	CcSEcCtD
Ranitidine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000384	0.00144	CcSEcCtD
Ranitidine—Neutropenia—Epirubicin—urinary bladder cancer	0.000383	0.00143	CcSEcCtD
Ranitidine—Dizziness—Thiotepa—urinary bladder cancer	0.000382	0.00143	CcSEcCtD
Ranitidine—Urticaria—Fluorouracil—urinary bladder cancer	0.00038	0.00142	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000379	0.00142	CcSEcCtD
Ranitidine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000378	0.00142	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000375	0.00141	CcSEcCtD
Ranitidine—Sweating—Methotrexate—urinary bladder cancer	0.000374	0.0014	CcSEcCtD
Ranitidine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000374	0.0014	CcSEcCtD
Ranitidine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000373	0.0014	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000371	0.00139	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—urinary bladder cancer	0.00037	0.00139	CcSEcCtD
Ranitidine—Dyspnoea—Etoposide—urinary bladder cancer	0.00037	0.00139	CcSEcCtD
Ranitidine—Somnolence—Etoposide—urinary bladder cancer	0.000369	0.00138	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000369	0.00138	CcSEcCtD
Ranitidine—Vomiting—Thiotepa—urinary bladder cancer	0.000367	0.00138	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—urinary bladder cancer	0.000367	0.00138	CcSEcCtD
Ranitidine—Rash—Thiotepa—urinary bladder cancer	0.000364	0.00137	CcSEcCtD
Ranitidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000364	0.00137	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000364	0.00136	CcSEcCtD
Ranitidine—Headache—Thiotepa—urinary bladder cancer	0.000362	0.00136	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00036	0.00135	CcSEcCtD
Ranitidine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000358	0.00134	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—urinary bladder cancer	0.000356	0.00133	CcSEcCtD
Ranitidine—Constipation—Etoposide—urinary bladder cancer	0.000355	0.00133	CcSEcCtD
Ranitidine—Pain—Etoposide—urinary bladder cancer	0.000355	0.00133	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000354	0.00133	CcSEcCtD
Ranitidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000352	0.00132	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—urinary bladder cancer	0.00035	0.00131	CcSEcCtD
Ranitidine—Sweating—Epirubicin—urinary bladder cancer	0.00035	0.00131	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000346	0.0013	CcSEcCtD
Ranitidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000344	0.00129	CcSEcCtD
Ranitidine—Nausea—Thiotepa—urinary bladder cancer	0.000343	0.00129	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000343	0.00128	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000342	0.00128	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00034	0.00128	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—urinary bladder cancer	0.00034	0.00127	CcSEcCtD
Ranitidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000338	0.00127	CcSEcCtD
Ranitidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000334	0.00125	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—urinary bladder cancer	0.000333	0.00125	CcSEcCtD
Ranitidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000333	0.00125	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000331	0.00124	CcSEcCtD
Ranitidine—Urticaria—Etoposide—urinary bladder cancer	0.00033	0.00124	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—urinary bladder cancer	0.000329	0.00123	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—urinary bladder cancer	0.000328	0.00123	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—urinary bladder cancer	0.000328	0.00123	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000328	0.00123	CcSEcCtD
Ranitidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000327	0.00123	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—urinary bladder cancer	0.000324	0.00121	CcSEcCtD
Ranitidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000316	0.00119	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000315	0.00118	CcSEcCtD
Ranitidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00031	0.00116	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00031	0.00116	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—urinary bladder cancer	0.000309	0.00116	CcSEcCtD
Ranitidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000309	0.00116	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000309	0.00116	CcSEcCtD
Ranitidine—Rash—Gemcitabine—urinary bladder cancer	0.000307	0.00115	CcSEcCtD
Ranitidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000306	0.00115	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000306	0.00115	CcSEcCtD
Ranitidine—Erythema—Methotrexate—urinary bladder cancer	0.000305	0.00114	CcSEcCtD
Ranitidine—Headache—Gemcitabine—urinary bladder cancer	0.000305	0.00114	CcSEcCtD
Ranitidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000304	0.00114	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000303	0.00114	CcSEcCtD
Ranitidine—Rash—Fluorouracil—urinary bladder cancer	0.000301	0.00113	CcSEcCtD
Ranitidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000301	0.00113	CcSEcCtD
Ranitidine—Headache—Fluorouracil—urinary bladder cancer	0.000299	0.00112	CcSEcCtD
Ranitidine—Pruritus—Etoposide—urinary bladder cancer	0.000294	0.0011	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000293	0.0011	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—urinary bladder cancer	0.000289	0.00109	CcSEcCtD
Ranitidine—Nausea—Gemcitabine—urinary bladder cancer	0.000289	0.00108	CcSEcCtD
Ranitidine—Vomiting—Cisplatin—urinary bladder cancer	0.000288	0.00108	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—urinary bladder cancer	0.000287	0.00108	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000287	0.00107	CcSEcCtD
Ranitidine—Rash—Cisplatin—urinary bladder cancer	0.000286	0.00107	CcSEcCtD
Ranitidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000285	0.00107	CcSEcCtD
Ranitidine—Erythema—Epirubicin—urinary bladder cancer	0.000285	0.00107	CcSEcCtD
Ranitidine—ABCB1—lymph node—urinary bladder cancer	0.000285	0.00601	CbGeAlD
Ranitidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000284	0.00107	CcSEcCtD
Ranitidine—Nausea—Fluorouracil—urinary bladder cancer	0.000284	0.00106	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000283	0.00106	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—urinary bladder cancer	0.000282	0.00106	CcSEcCtD
Ranitidine—Malaise—Methotrexate—urinary bladder cancer	0.000275	0.00103	CcSEcCtD
Ranitidine—Dizziness—Etoposide—urinary bladder cancer	0.000275	0.00103	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—urinary bladder cancer	0.000274	0.00103	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—urinary bladder cancer	0.000273	0.00102	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000271	0.00102	CcSEcCtD
Ranitidine—Nausea—Cisplatin—urinary bladder cancer	0.000269	0.00101	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—urinary bladder cancer	0.000269	0.00101	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—urinary bladder cancer	0.000268	0.001	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000265	0.000992	CcSEcCtD
Ranitidine—Vomiting—Etoposide—urinary bladder cancer	0.000264	0.00099	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—urinary bladder cancer	0.000264	0.000989	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—urinary bladder cancer	0.000264	0.000988	CcSEcCtD
Ranitidine—Agitation—Epirubicin—urinary bladder cancer	0.000262	0.000983	CcSEcCtD
Ranitidine—Rash—Etoposide—urinary bladder cancer	0.000262	0.000982	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—urinary bladder cancer	0.000262	0.000981	CcSEcCtD
Ranitidine—Headache—Etoposide—urinary bladder cancer	0.00026	0.000975	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—urinary bladder cancer	0.000259	0.000973	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—urinary bladder cancer	0.000259	0.000973	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—urinary bladder cancer	0.000259	0.000973	CcSEcCtD
Ranitidine—Malaise—Epirubicin—urinary bladder cancer	0.000257	0.000964	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—urinary bladder cancer	0.000256	0.000961	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—urinary bladder cancer	0.000256	0.000961	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—urinary bladder cancer	0.000255	0.000957	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—urinary bladder cancer	0.000251	0.00094	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000249	0.000932	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000249	0.000932	CcSEcCtD
Ranitidine—Nausea—Etoposide—urinary bladder cancer	0.000247	0.000925	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000245	0.000918	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—urinary bladder cancer	0.000244	0.000914	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000243	0.000913	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—urinary bladder cancer	0.000243	0.00091	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—urinary bladder cancer	0.000243	0.00091	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—urinary bladder cancer	0.000243	0.00091	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—urinary bladder cancer	0.000242	0.000909	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00024	0.000901	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—urinary bladder cancer	0.00024	0.000899	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—urinary bladder cancer	0.000238	0.000892	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—urinary bladder cancer	0.000237	0.000889	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000236	0.000886	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—urinary bladder cancer	0.000235	0.00088	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000233	0.000873	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—urinary bladder cancer	0.000232	0.000871	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000228	0.000854	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—urinary bladder cancer	0.000227	0.000852	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000227	0.00085	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000225	0.000844	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—urinary bladder cancer	0.000225	0.000843	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000225	0.000842	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—urinary bladder cancer	0.000225	0.000842	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—urinary bladder cancer	0.000225	0.000842	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—urinary bladder cancer	0.000222	0.000832	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000222	0.000831	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—urinary bladder cancer	0.000221	0.000829	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—urinary bladder cancer	0.000217	0.000815	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000217	0.000814	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000215	0.000807	CcSEcCtD
Ranitidine—Pain—Methotrexate—urinary bladder cancer	0.000213	0.000797	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000212	0.000795	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000211	0.000791	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—urinary bladder cancer	0.00021	0.000789	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00021	0.000788	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000208	0.000781	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000207	0.000778	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—urinary bladder cancer	0.000207	0.000776	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000205	0.000768	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—urinary bladder cancer	0.000201	0.000754	CcSEcCtD
Ranitidine—Constipation—Epirubicin—urinary bladder cancer	0.000199	0.000746	CcSEcCtD
Ranitidine—Pain—Epirubicin—urinary bladder cancer	0.000199	0.000746	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—urinary bladder cancer	0.000198	0.000741	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000197	0.000737	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000197	0.000737	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000196	0.000736	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—urinary bladder cancer	0.000195	0.00073	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000192	0.00072	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000192	0.000719	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—urinary bladder cancer	0.000191	0.000718	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—urinary bladder cancer	0.000185	0.000693	CcSEcCtD
Ranitidine—Pain—Doxorubicin—urinary bladder cancer	0.000184	0.00069	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—urinary bladder cancer	0.000184	0.00069	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000184	0.00069	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000184	0.00069	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000183	0.000687	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000177	0.000665	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—urinary bladder cancer	0.000176	0.00066	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000171	0.000643	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—urinary bladder cancer	0.000171	0.000641	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00017	0.000638	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00017	0.000638	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00017	0.000638	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—urinary bladder cancer	0.000165	0.000617	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—urinary bladder cancer	0.000164	0.000617	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000159	0.000597	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000159	0.000595	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—urinary bladder cancer	0.000158	0.000593	CcSEcCtD
Ranitidine—Rash—Methotrexate—urinary bladder cancer	0.000157	0.000588	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—urinary bladder cancer	0.000157	0.000587	CcSEcCtD
Ranitidine—Headache—Methotrexate—urinary bladder cancer	0.000156	0.000584	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—urinary bladder cancer	0.000154	0.000577	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—urinary bladder cancer	0.000152	0.000571	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—urinary bladder cancer	0.000148	0.000555	CcSEcCtD
Ranitidine—Nausea—Methotrexate—urinary bladder cancer	0.000148	0.000554	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000147	0.000552	CcSEcCtD
Ranitidine—Rash—Epirubicin—urinary bladder cancer	0.000147	0.00055	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—urinary bladder cancer	0.000147	0.00055	CcSEcCtD
Ranitidine—Headache—Epirubicin—urinary bladder cancer	0.000146	0.000547	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—urinary bladder cancer	0.000142	0.000534	CcSEcCtD
Ranitidine—Nausea—Epirubicin—urinary bladder cancer	0.000138	0.000518	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—urinary bladder cancer	0.000137	0.000513	CcSEcCtD
Ranitidine—Rash—Doxorubicin—urinary bladder cancer	0.000136	0.000509	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000136	0.000509	CcSEcCtD
Ranitidine—Headache—Doxorubicin—urinary bladder cancer	0.000135	0.000506	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—urinary bladder cancer	0.000128	0.00048	CcSEcCtD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.78e-05	0.000716	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.71e-05	0.000708	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.68e-05	0.000705	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.66e-05	0.000702	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RBX1—urinary bladder cancer	6.55e-05	0.000692	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.53e-05	0.00069	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	6.35e-05	0.000671	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.29e-05	0.000664	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.18e-05	0.000652	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TSC1—urinary bladder cancer	6.16e-05	0.00065	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.14e-05	0.000648	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.09e-05	0.000643	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.09e-05	0.000643	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TYMP—urinary bladder cancer	6.02e-05	0.000635	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	6e-05	0.000633	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.97e-05	0.00063	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.97e-05	0.00063	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.87e-05	0.000619	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JAG1—urinary bladder cancer	5.86e-05	0.000619	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	5.85e-05	0.000617	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.83e-05	0.000616	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.82e-05	0.000615	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.82e-05	0.000615	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	5.79e-05	0.000611	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.76e-05	0.000608	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.68e-05	0.000599	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.6e-05	0.000591	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.49e-05	0.000579	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.49e-05	0.000579	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.46e-05	0.000576	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NAT2—urinary bladder cancer	5.44e-05	0.000575	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.33e-05	0.000562	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.02e-05	0.00053	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—RHOA—urinary bladder cancer	4.96e-05	0.000523	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.95e-05	0.000522	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.91e-05	0.000519	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.9e-05	0.000518	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.89e-05	0.000516	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.8e-05	0.000506	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.78e-05	0.000504	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—S100B—urinary bladder cancer	4.75e-05	0.000501	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—RRM2—urinary bladder cancer	4.7e-05	0.000496	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	4.68e-05	0.000493	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.65e-05	0.000491	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.65e-05	0.000491	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.64e-05	0.00049	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.57e-05	0.000483	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.53e-05	0.000478	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.52e-05	0.000477	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.52e-05	0.000477	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—RHOA—urinary bladder cancer	4.5e-05	0.000475	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.47e-05	0.000472	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.41e-05	0.000466	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.35e-05	0.000459	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ENO2—urinary bladder cancer	4.35e-05	0.000459	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	4.35e-05	0.000459	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.32e-05	0.000456	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NCOR1—urinary bladder cancer	4.27e-05	0.000451	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.27e-05	0.00045	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.25e-05	0.000449	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	4.23e-05	0.000446	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	4.22e-05	0.000445	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.18e-05	0.000441	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.17e-05	0.00044	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2—urinary bladder cancer	4.16e-05	0.000439	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.16e-05	0.000439	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.97e-05	0.000419	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL8—urinary bladder cancer	3.95e-05	0.000417	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.95e-05	0.000417	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.86e-05	0.000408	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.83e-05	0.000404	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.78e-05	0.000399	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2—urinary bladder cancer	3.78e-05	0.000399	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TERT—urinary bladder cancer	3.76e-05	0.000397	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.65e-05	0.000385	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.63e-05	0.000383	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.61e-05	0.000382	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.61e-05	0.000381	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.59e-05	0.000379	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.59e-05	0.000379	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.53e-05	0.000372	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.52e-05	0.000372	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NQO1—urinary bladder cancer	3.51e-05	0.00037	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.47e-05	0.000366	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.46e-05	0.000365	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGFR3—urinary bladder cancer	3.45e-05	0.000365	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	3.43e-05	0.000362	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.39e-05	0.000357	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.38e-05	0.000357	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.38e-05	0.000357	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ESR1—urinary bladder cancer	3.35e-05	0.000354	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.32e-05	0.000351	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.28e-05	0.000346	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.28e-05	0.000346	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.27e-05	0.000345	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.22e-05	0.00034	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.2e-05	0.000338	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.19e-05	0.000337	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.01e-05	0.000317	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.95e-05	0.000312	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CREBBP—urinary bladder cancer	2.94e-05	0.00031	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	2.93e-05	0.000309	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IGF1—urinary bladder cancer	2.9e-05	0.000306	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—urinary bladder cancer	2.89e-05	0.000305	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.84e-05	0.0003	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.82e-05	0.000298	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.82e-05	0.000298	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.82e-05	0.000297	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.79e-05	0.000294	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.75e-05	0.000291	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—KRAS—urinary bladder cancer	2.73e-05	0.000288	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.72e-05	0.000288	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	2.72e-05	0.000287	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.72e-05	0.000287	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.7e-05	0.000285	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	2.69e-05	0.000284	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	2.69e-05	0.000284	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RHOA—urinary bladder cancer	2.66e-05	0.000281	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.61e-05	0.000276	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.61e-05	0.000276	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.6e-05	0.000274	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.6e-05	0.000274	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	2.57e-05	0.000272	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.55e-05	0.000269	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.55e-05	0.000269	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.55e-05	0.000269	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.53e-05	0.000268	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	2.53e-05	0.000267	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.5e-05	0.000263	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.47e-05	0.000261	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ERBB2—urinary bladder cancer	2.46e-05	0.00026	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.4e-05	0.000254	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.4e-05	0.000254	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	2.38e-05	0.000251	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—urinary bladder cancer	2.33e-05	0.000246	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.33e-05	0.000246	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HRAS—urinary bladder cancer	2.32e-05	0.000245	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.32e-05	0.000244	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.27e-05	0.00024	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—urinary bladder cancer	2.23e-05	0.000236	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.2e-05	0.000232	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—urinary bladder cancer	2.18e-05	0.00023	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.17e-05	0.000229	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.11e-05	0.000223	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—urinary bladder cancer	2.11e-05	0.000223	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.11e-05	0.000222	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.1e-05	0.000222	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—urinary bladder cancer	2.1e-05	0.000222	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.09e-05	0.00022	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.09e-05	0.00022	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.06e-05	0.000217	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.04e-05	0.000216	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.04e-05	0.000215	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.04e-05	0.000215	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.02e-05	0.000214	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EP300—urinary bladder cancer	2e-05	0.000211	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2e-05	0.000211	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.000208	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.97e-05	0.000207	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.96e-05	0.000207	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SRC—urinary bladder cancer	1.95e-05	0.000205	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.94e-05	0.000205	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.94e-05	0.000204	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.93e-05	0.000203	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	1.85e-05	0.000195	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	0.000195	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.78e-05	0.000188	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.76e-05	0.000185	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—urinary bladder cancer	1.74e-05	0.000184	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.71e-05	0.000181	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—urinary bladder cancer	1.71e-05	0.00018	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.7e-05	0.000179	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.7e-05	0.000179	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.64e-05	0.000173	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.63e-05	0.000172	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.62e-05	0.000171	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.61e-05	0.00017	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.61e-05	0.00017	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—urinary bladder cancer	1.61e-05	0.00017	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.59e-05	0.000168	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.59e-05	0.000168	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.58e-05	0.000166	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.58e-05	0.000166	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.57e-05	0.000166	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.57e-05	0.000166	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.55e-05	0.000163	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.52e-05	0.000161	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.52e-05	0.00016	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	1.52e-05	0.00016	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.51e-05	0.000159	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.5e-05	0.000159	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.5e-05	0.000158	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.48e-05	0.000157	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.48e-05	0.000157	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.48e-05	0.000156	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.000152	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—urinary bladder cancer	1.43e-05	0.000151	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.43e-05	0.000151	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.42e-05	0.00015	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.4e-05	0.000147	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.39e-05	0.000147	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.39e-05	0.000147	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—urinary bladder cancer	1.37e-05	0.000145	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	0.000144	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.32e-05	0.00014	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	1.32e-05	0.00014	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.31e-05	0.000139	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000134	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.27e-05	0.000134	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—EP300—urinary bladder cancer	1.26e-05	0.000133	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.000133	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.000133	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000127	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000125	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000124	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.16e-05	0.000122	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.13e-05	0.000119	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000117	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	0.000117	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	0.000114	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.06e-05	0.000112	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.06e-05	0.000112	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.000108	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.02e-05	0.000108	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.82e-06	0.000104	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—EP300—urinary bladder cancer	9.79e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.71e-06	0.000102	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.71e-06	0.000102	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.3e-06	9.81e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.13e-06	9.63e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.1e-06	9.61e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	9.01e-06	9.51e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.88e-06	9.38e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.66e-06	9.14e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.58e-06	9.06e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	8.37e-06	8.84e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.94e-06	8.38e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.75e-06	8.18e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.57e-06	7.99e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—EP300—urinary bladder cancer	7.39e-06	7.8e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.3e-06	7.71e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	7.09e-06	7.48e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.96e-06	7.35e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.96e-06	7.34e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.68e-06	7.05e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.18e-06	6.53e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.9e-06	6.23e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.47e-06	5.78e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.77e-06	5.04e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.55e-06	4.8e-05	CbGpPWpGaD
